CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-02 | Opaleye Management Inc. 10% owner | Sale | −65,000 | $37.39 | $2.4M | 2,710,000 |
| 2026-07-02 | Opaleye Management Inc. 10% owner | Sale | −25,000 | $37.39 | $935K | 60,000 |
| 2026-06-26 | Krempa David Chief Business Officer | Grant or award · Restricted Stock Units | +10,000 | 96,829 | ||
| 2026-06-17 | Adams Jennifer McKie Director | Option exercise | +50,000 | $3.78 | $189K | 50,000 |
| 2026-06-17 | Adams Jennifer McKie Director | Sale | −50,000 | $32.48 | $1.6M | 0 |
| 2026-06-17 | Adams Jennifer McKie Director | Option exercise · Employee Stock Option | −50,000 | 0 | ||
| 2026-05-28 | BRYNJELSEN SEAN President & CEO | Sale | −119,852 | $31.88 | $3.8M | 833,842 |
| 2026-05-28 | BRYNJELSEN SEAN President & CEO | Sale | −148 | $32.67 | $5K | 833,694 |
| 2026-05-27 | Krempa David Chief Business Officer | Option exercise | +12,476 | $1.37 | $17K | 37,725 |
| 2026-05-27 | Krempa David Chief Business Officer | Option exercise | +7,203 | $3.58 | $26K | 44,928 |
| 2026-05-27 | Krempa David Chief Business Officer | Sale | −19,679 | $31.47 | $619K | 25,249 |
| 2026-05-27 | Krempa David Chief Business Officer | Option exercise · Employee Stock Option | −12,476 | 0 | ||
| 2026-05-27 | Krempa David Chief Business Officer | Option exercise · Employee Stock Option | −7,203 | 118,406 | ||
| 2026-05-26 | Krempa David Chief Business Officer | Option exercise | +25,000 | $1.38 | $35K | 50,249 |
| 2026-05-26 | Krempa David Chief Business Officer | Option exercise | +12,524 | $1.37 | $17K | 62,773 |
| 2026-05-26 | Krempa David Chief Business Officer | Sale | −37,524 | $31.49 | $1.2M | 25,249 |
| 2026-05-26 | Krempa David Chief Business Officer | Option exercise · Employee Stock Option | −25,000 | 0 | ||
| 2026-05-26 | Krempa David Chief Business Officer | Option exercise · Employee Stock Option | −12,524 | 12,476 | ||
| 2026-05-22 | Krempa David Chief Business Officer | Option exercise | +30,591 | $3.58 | $110K | 68,046 |
| 2026-05-22 | Krempa David Chief Business Officer | Sale | −32,963 | $33.22 | $1.1M | 35,083 |
Page 4 of 13 · 249 trades